Back
Matinas BioPharma Holdings Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.58
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Matinas BioPharma Holdings Price Quote
$0.58
+0.00 (+7.41%)
(Updated: November 22, 2024 at 5:37 AM ET)
Matinas BioPharma Holdings Key Stats
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Day range:
$0.53 - $0.58
52-week range:
$0.50 - $21.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.63
P/B ratio:
0.19%
Volume:
119.9K
Avg. volume:
394.9K
1-year change:
-94.59%
Market cap:
$3M
Revenue:
$1.1M
EPS:
$-4.79
How Much Does Matinas BioPharma Holdings Make?
Data Unavailable
Is Matinas BioPharma Holdings Growing As A Company?
Data Unavailable
Matinas BioPharma Holdings Stock Price Performance
-
Did Matinas BioPharma Holdings Stock Go Up Last Month?
Matinas BioPharma Holdings share price went down by -84.45% last month -
Did MTNB's Share Price Rise Over The Last Year?
MTNB share price fell by -94.59% over the past 1 year
What Is Matinas BioPharma Holdings 52-Week High & Low?
-
What Is Matinas BioPharma Holdings’s 52-Week High Share Price?
Matinas BioPharma Holdings has traded as high as $21.50 over the past 52 weeks -
What Is Matinas BioPharma Holdings’s 52-Week Low Share Price?
Matinas BioPharma Holdings has traded as low as $0.50 over the past 52 weeks
Matinas BioPharma Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Matinas BioPharma Holdings?
-
How Much Debt Does Matinas BioPharma Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Matinas BioPharma Holdings Have?
Cash and short term investments quarterly total is $10.8M -
What Is Matinas BioPharma Holdings’s Book Value Per Share?
Book value per share is 3.10
Is Matinas BioPharma Holdings Cash Flow Positive?
-
What Is MTNB Cash Flow From Operations?
Cash flow from operations (TTM) is -$17M -
What Is Matinas BioPharma Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $9.2M -
What Is Matinas BioPharma Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is $11.7M
Matinas BioPharma Holdings Return On Invested Capital
Data Unavailable
Matinas BioPharma Holdings Earnings Date & Stock Price
-
What Is Matinas BioPharma Holdings's Stock Price Today?
A single share of MTNB can be purchased today for 0.58 -
What Is Matinas BioPharma Holdings’s Stock Symbol?
Matinas BioPharma Holdings trades on the nyam under the ticker symbol: MTNB -
When Is Matinas BioPharma Holdings’s Next Earnings Date?
The next quarterly earnings date for Matinas BioPharma Holdings is scheduled on March 27, 2025 -
When Is MTNB's next ex-dividend date?
Matinas BioPharma Holdings's next ex-dividend date is May 16, 2020 -
How To Buy Matinas BioPharma Holdings Stock?
You can buy Matinas BioPharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Matinas BioPharma Holdings Competitors
-
Who Are Matinas BioPharma Holdings's Competitors?
Below is a list of companies who compete with Matinas BioPharma Holdings or are related in some way:
Matinas BioPharma Holdings Dividend Yield
-
What Is MTNB Dividend Yield?
Matinas BioPharma Holdings’s dividend yield currently is 0% -
What Is Matinas BioPharma Holdings’s Payout Ratio?
Matinas BioPharma Holdings’s payout ratio is 0% -
When Did Matinas BioPharma Holdings Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Matinas BioPharma Holdings’s Dividend Per Share?
Matinas BioPharma Holdings pays a dividend of $0.00 per share
Matinas BioPharma Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 19.43% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 30.00 |
| Upside from Last Price: | 5073.31% |